Kraig Biocraft Laboratories (KBLB) Amortization of Deferred Charges (2010 - 2025)

Kraig Biocraft Laboratories' Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $18803.0 for Q4 2025.

• In Q4 2025, Amortization of Deferred Charges fell 7.73% year-over-year to $18803.0; the TTM figure through Dec 2025 stood at $79497.0 (down 1.94% YoY), while the FY2025 annual figure was $79275.0, down 2.22% from the prior year.
• Amortization of Deferred Charges came in at $18803.0 for Q4 2025 at Kraig Biocraft Laboratories, down from $20379.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q3 2021 to a low of $18803.0 in Q4 2025.
• A 5-year average of $317683.3 and a median of $20379.0 in 2023 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges jumped 53.73% in 2022 and tumbled 94.89% in 2023, its largest moves.
• Kraig Biocraft Laboratories' Amortization of Deferred Charges stood at $529963.0 in 2021, then slipped by 24.79% to $398603.0 in 2022, then sank by 94.89% to $20379.0 in 2023, then changed by 0.0% to $20379.0 in 2024, then dropped by 7.73% to $18803.0 in 2025.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $18803.0, $20379.0, and $20379.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison